You have not persuaded me that any of the events you mention will have an earlier effect on Amarin share price than interim look or news of next supplemental filings with FDA per settlement agreement with FDA. An earlier buy out offer or SEC filing by other companies are cards on the table having the potential to also affect share price
My only point...the antitrust "concerns" are valid and IMO actively in play. Hopefully our DOJ will actually promote justice and Constitutional compliance... This could speed up numerous Amarin time tables.